Eight-plasmid system for rapid generation of influenza virus vaccines - PubMed (original) (raw)
Comparative Study
. 2002 Aug 19;20(25-26):3165-70.
doi: 10.1016/s0264-410x(02)00268-2.
Affiliations
- PMID: 12163268
- DOI: 10.1016/s0264-410x(02)00268-2
Comparative Study
Eight-plasmid system for rapid generation of influenza virus vaccines
Erich Hoffmann et al. Vaccine. 2002.
Abstract
The antigenic variation of influenza A virus hemagglutinin (HA) and neuraminidase (NA) glycoproteins requires frequent changes in vaccine formulation. The classical method of creating influenza virus seed strains for vaccine production is to generate 6 + 2 reassortants that contain six genes from a high-yield virus, such as A/PR/8/34 (H1N1) and the HA and NA genes of the circulating strains. The techniques currently used are time-consuming because of the selection process required to isolate the reassortant virus. We generated the high-yield virus A/PR/8/34 (H1N1) entirely from eight plasmids. Its growth phenotype in embryonated chicken eggs was equivalent to that of the wild-type virus. By using this DNA-based cotransfection technique, we generated 6 + 2 reassortants that had the antigenic determinants of the influenza virus strains A/New Caledonia/20/99 (H1N1), A/Panama/2007/99 (H3N2), A/teal/HK/W312 (H6N1), and A/quail/HK/G1/97 (H9N2). Our findings demonstrate that the eight-plasmid system allows the rapid and reproducible generation of reassortant influenza A viruses for use in the manufacture of vaccines.
Copyright 2002 Elsevier Science Ltd.
Similar articles
- Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T, Kiseleva I, Johnston K, Su Q, Toner T, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Wlochowski J, Monteiro J, Kraiouchkine N, DiStefano D, Rudenko L, Shaw A, Youil R. Palker T, et al. Virus Res. 2004 Oct;105(2):183-94. doi: 10.1016/j.virusres.2004.05.009. Virus Res. 2004. PMID: 15351492 - Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production.
Fulvini AA, Ramanunninair M, Le J, Pokorny BA, Arroyo JM, Silverman J, Devis R, Bucher D. Fulvini AA, et al. PLoS One. 2011;6(6):e20823. doi: 10.1371/journal.pone.0020823. Epub 2011 Jun 13. PLoS One. 2011. PMID: 21695145 Free PMC article. - Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
Zhang W, Xue T, Wu X, Zhang P, Zhao G, Peng D, Hu S, Wang X, Liu X, Liu W, Liu X. Zhang W, et al. Vaccine. 2011 Oct 19;29(45):8032-41. doi: 10.1016/j.vaccine.2011.08.054. Epub 2011 Aug 22. Vaccine. 2011. PMID: 21864614 - Developments in high-yield system expressed vaccines and immunotherapy.
Geels M, Ye K. Geels M, et al. Recent Pat Biotechnol. 2010 Nov;4(3):189-97. doi: 10.2174/187220810793611518. Recent Pat Biotechnol. 2010. PMID: 21171956 Free PMC article. Review.
Cited by
- Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine.
Cargnin Faccin F, Cáceres CJ, Gay LC, Seibert B, van Bentem N, Rodriguez LA, Soares Fraiha AL, Cardenas M, Geiger G, Ortiz L, Carnaccini S, Kapczynski DR, Rajao DS, Perez DR. Cargnin Faccin F, et al. NPJ Vaccines. 2024 Aug 3;9(1):136. doi: 10.1038/s41541-024-00923-y. NPJ Vaccines. 2024. PMID: 39097573 Free PMC article. - Production of Disinfective Coating Layer to Facial Masks Supplemented with Camellia sinensis Extract.
Abd-Elshafy DN, Abdallah H, Nadeem R, Shalaby MS, Shaban AM, Bahgat MM. Abd-Elshafy DN, et al. Curr Microbiol. 2024 May 31;81(7):198. doi: 10.1007/s00284-024-03741-6. Curr Microbiol. 2024. PMID: 38819647 - Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets.
Halwe NJ, Hamberger L, Sehl-Ewert J, Mache C, Schön J, Ulrich L, Calvelage S, Tönnies M, Fuchs J, Bandawane P, Loganathan M, Abbad A, Carreño JM, Bermúdez-González MC, Simon V, Kandeil A, El-Shesheny R, Ali MA, Kayali G, Budt M, Hippenstiel S, Hocke AC, Krammer F, Wolff T, Schwemmle M, Ciminski K, Hoffmann D, Beer M. Halwe NJ, et al. Nat Commun. 2024 Apr 25;15(1):3450. doi: 10.1038/s41467-024-47455-6. Nat Commun. 2024. PMID: 38664395 Free PMC article. - Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus.
Wong PF, Isakova-Sivak I, Stepanova E, Krutikova E, Bazhenova E, Rekstin A, Rudenko L. Wong PF, et al. Vaccines (Basel). 2024 Jan 18;12(1):95. doi: 10.3390/vaccines12010095. Vaccines (Basel). 2024. PMID: 38250908 Free PMC article. - N-terminal acetylation separately promotes nuclear localization and host shutoff activity of the influenza A virus ribonuclease PA-X.
Daly RE, Myasnikov I, Gaglia MM. Daly RE, et al. bioRxiv [Preprint]. 2024 Jan 25:2023.12.01.569683. doi: 10.1101/2023.12.01.569683. bioRxiv. 2024. PMID: 38076881 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials